News

The realignment will result in the elimination of a number of positions and additional refinement to Elan’s commercial activities in Tysabri for Crohn’s disease. Elan has also decided

Both patents are associated with emtricitabine, a component of Truvada and are licensed exclusively to Gilead Sciences by Emory University. Truvada is indicated in combination with other antiretroviral

Momenta estimates that net proceeds from the offering will be approximately $24.1 million, after deducting placement agent fees and estimated offering expenses. Momenta currently intends to use the

Under the terms of the agreement, all pending disputes between the companies will be immediately dismissed. In addition, the companies have agreed to cross license certain patents. The

Aetna will collaborate with Gateway Healthcare to provide administrative and financial services to outpatient care practices (OCPs) in Dubai. The two companies will also offer management services like

Pfizer laid the blame on the rising R&D costs, increasing generic competition and tougher drug regulations for its restructuring operations in France. The global pharmaceutical industry has seen

In the preliminary analysis, 18% of patients (n=23) given a regimen of Abraxane (nab-paclitaxel), gemcitabine and epirubicin achieved a complete pathologic response and 68% (n=84) achieved a partial

The advisory committee voted 15-0 that the product is approvable with the condition that the FC2 Female Condom’s instructions for use continue to follow use instructions for the

Mr Kenyon has accepted a full time position as executive vice president of finance at Par Pharmaceutical, effective December 15, 2008. In addition, the company has also announced